Prestige BioPharma Limited (KRX:950210)

Revenue by Segment

Financials in millions KRW. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Biotechnology (Startups)	161.84M	-	-
Total	161.84M	-	-

Revenue by Geography

Financials in millions KRW. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Singapore	161.84M	-	-
Total	161.84M	-	-

Data Source: S&P Global Market Intelligence Last updated: May 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 18, 2026

Data Sources Report a data error